Travere Therapeutics, Inc. (TVTX) has 10 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $45.7M. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | ROTE WILLIAM E. Chief Research Officer | −$1,102,617 | 592,048 | −100% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | REED ELIZABETH E Chief Legal Officer and GC | $1,757,945 | 112,500 | — | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | −$1,576,494 | 799,567 | −36% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Inrig Jula EVP, Head of R&D & CMO | −$765,485 | 109,464 | −22% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Cline Christopher R. CHIEF FINANCIAL OFFICER | −$1,901,793 | 90,508 | −100% | Yes | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free